文献速递炎症性肠病

炎症性肠病术后无治疗结局:全国性队列研究

Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study.
PubMed 文献 · Aliment Pharmacol Ther · 2025-10-21

该全国性队列研究纳入2007至2018年瑞典首次因克罗恩病(CD)行肠切除或溃疡性结肠炎(UC)行全结肠切除的1709例CD和1010例UC患者,评估术后5年内无需IBD相关治疗的比例。结果显示,术后5年无治疗比例CD为21.5%、UC为42.4%,肠外表现者无治疗可能性更低(CD aOR 0.64,95%CI 0.43-0.97;UC aOR 0.48,95%CI 0.31-0.73)。

要点

  • 术后5年无治疗比例:CD 21.5%,UC 42.4%。
  • 肠外表现降低术后无治疗可能性(CD aOR 0.64;UC aOR 0.48)。
  • CD术前病程长、UC年龄较大者更可能术后无治疗。

核心结论

  • 手术可使22%的CD患者和42%的UC患者在术后5年内无需未来治疗。

研究设计与样本

  • 全国性队列研究,使用瑞典国家患者登记和ESPRESSO组织病理学数据,纳入2007至2018年首次因CD行肠切除或UC行全结肠切除的1709例CD和1010例UC患者。

主要发现

  • 术后5年,21.5%的CD患者和42.4%的UC患者保持无治疗。
  • CD术前病程较长和UC年龄较大的患者术后5年无治疗更常见。
  • 有肠外表现者无治疗可能性更低(CD aOR 0.64,95%CI 0.43-0.97;UC aOR 0.48,95%CI 0.31-0.73)。
  • CD合并慢性阻塞性肺疾病者无治疗可能性更低。

临床怎么用

  • 对于CD术前病程较长、无肠外表现且无COPD者,以及UC年龄较大、无肠外表现者,可考虑精准手术以争取长期无治疗获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgery in select individuals with inflammatory bowel disease (IBD) may obviate the need for future IBD-related treatment. AIMS: To characterise individuals who remain treatment-free during the first 5 years after initial IBD-related surgery. METHODS: We performed a nationwide cohort study using the Swedish National Patient Register and the ESPRESSO histopathology to identify individuals undergoing first IBD-related intestinal resection for Crohn's disease (CD) or total colectomy for ulcerative colitis (UC) between 2007 and 2018. We calculated adjusted odds ratios (aORs) for the need for any IBD-related therapy within the first 5 years post surgery. RESULTS: We included 1709 individuals with CD and 1010 with UC. At 5 years, 21.5% with CD and 42.4% with UC remained 'treatment free'. Being 'treatment free' 5 years after surgery was more common among patients with CD who had longer preoperative disease duration and older adults with UC. It was less common among individuals with extraintestinal manifestations of disease (CD aOR 0.64, 95% CI 0.43-0.97; UC aOR 0.48, 95% CI 0.31-0.73) and patients with CD who had chronic obstructive pulmonary disease. CONCLUSIONS: Surgery obviated the need for future therapy in 22% of patients with CD and 42% with UC. Absence of extraintestinal manifestations, older age in UC, and longer disease duration and absence of chronic obstructive pulmonary disease in CD may highlight an opportunity for precision surgery to identify those most likely to achieve long-term benefit from surgical intervention.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Faye AS, Axelrad J, Sun J, et al. Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study. Aliment Pharmacol Ther. 2025. PMID: 41121721. doi:10.1111/apt.70432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。